Prostate Cancer

Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial. June 5, 2023

Genetically adjusted PSA levels for prostate cancer screening. June 5, 2023

Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group Study. June 5, 2023

Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer. June 5, 2023

Supportive interventions for carers of men with prostate cancer: systematic review and narrative synthesis. June 5, 2023

Genitourinary Radiation Injury Following Prostate Cancer Treatment: Assessment of Cost and Health Care System Burden. June 5, 2023

3-Year Freedom from Progression After 68Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial. June 3, 2023

The Influence of Lifestyle Changes (Diet, Exercise and Stress Reduction) on Prostate Cancer Tumour Biology and Patient Outcomes: A Systematic Review June 2, 2023

Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial June 2, 2023

Abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer: a real-world retrospective study in China. June 2, 2023

The role of AI in prostate MRI quality and interpretation: Opportunities and challenges. June 2, 2023

A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA database. June 2, 2023

Symptom appraisal and help seeking in males with symptoms of possible prostate cancer: a qualitative study with an ethnically diverse sample in London. June 2, 2023

Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand. June 2, 2023

Transcriptome-Wide Association Analysis Identifies Novel Candidate Susceptibility Genes for Prostate-Specific Antigen Levels in Men Without Prostate Cancer. June 2, 2023

Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysis. June 2, 2023

Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer June 1, 2023

LYNPARZA® (Olaparib) plus Abiraterone Approved in the US for the Treatment of BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer June 1, 2023

FDA Approves Olaparib with Abiraterone and Prednisone (Or Prednisolone) for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer June 1, 2023

Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone Therapy. June 1, 2023

Page 1 of 1305